MetaADEDB 2.0 @ LMMD
Penicillin G
(FCPVYOBCFFNJFS-LQDWTQKMSA-M)
Structure
SMILES
O=C(Cc1ccccc1)N[C@@H]1C(=O)N2[C@@H]1SC([C@@H]2C(=O)[O-])(C)C.[Na+]
Molecular Formula:
C16H17N2NaO4S
Molecular Weight:
356.372
Log P:
-0.1451
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
1
TPSA:
114.84
CAS Number(s):
69-57-8
Synonym(s)
1.
Penicillin G
2.
Benzylpenicillin
3.
Benpen
4.
Benzylpenicillin Potassium
5.
Coliriocilina
6.
Crystapen
7.
Or-pen
8.
Parcillin
9.
Pekamin
10.
Pengesod
11.
Penibiot
12.
Penicilina G Llorente
13.
Penicillin G Jenapharm
14.
Penicillin G Potassium
15.
Penicillin G Sodium
16.
Penicillin Grünenthal
17.
Penilevel
18.
Peniroger
19.
Pfizerpen
20.
Sodiopen
21.
Sodipen
22.
Sodium Benzylpenicillin
23.
Sodium Penicillin
24.
Unicilina
25.
Ursopen
26.
Van-Pen-G
External Link(s)
MeSHD010400
PubChem Compound23668834
101603129
BindingDB50292583
ChEBI51765
CHEMBLCHEMBL1126
KEGGdr:D05408
Therapeutic Target DatabaseD0K5OT
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1HypersensitivityFAERS: 140US FAERS
2UrticariaFAERS: 6
Canada Vigilance: 5		Canada Vigilance
US FAERS
3Electrolyte imbalanceFAERS: 2US FAERS
4SwellingFAERS: 2US FAERS
5VomitingFAERS: 2
Canada Vigilance: 1		Canada Vigilance
US FAERS
6Wrong technique in drug usage processFAERS: 2US FAERS
7Acute kidney injuryFAERS: 1US FAERS
8Blood creatinine increasedFAERS: 1US FAERS
9DizzinessFAERS: 1US FAERS
10ErythemaFAERS: 1
Canada Vigilance: 2		Canada Vigilance
US FAERS
11Feeling abnormalFAERS: 1US FAERS
12FlushingFAERS: 1US FAERS
13Incorrect dose administeredFAERS: 1US FAERS
14Product physical issueFAERS: 1US FAERS
15PruritusFAERS: 1
Canada Vigilance: 3		Canada Vigilance
US FAERS
16VertigoFAERS: 1US FAERS
17Anaphylactoid ReactionCanada Vigilance: 1Canada Vigilance
18Chest discomfortCanada Vigilance: 2Canada Vigilance
19CyanosisCanada Vigilance: 1Canada Vigilance
20Fixed eruptionCanada Vigilance: 1Canada Vigilance
21NauseaCanada Vigilance: 1Canada Vigilance
22Oral candidiasisCanada Vigilance: 1Canada Vigilance
23Rash erythematousCanada Vigilance: 2Canada Vigilance
24Stevens-Johnson SyndromeCanada Vigilance: 1Canada Vigilance
25TachycardiaCanada Vigilance: 1Canada Vigilance
26TremorCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.